tiprankstipranks
Trending News
More News >
Recce Pharmaceuticals Ltd. (AU:RCE)
:RCE
Advertisement

Recce Pharmaceuticals Ltd. (RCE) Stock Statistics & Valuation Metrics

Compare
16 Followers

Total Valuation

Recce Pharmaceuticals Ltd. has a market cap or net worth of AU$120.01M. The enterprise value is AU$70.42M.
Market CapAU$120.01M
Enterprise ValueAU$70.42M

Share Statistics

Recce Pharmaceuticals Ltd. has 289,183,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding289,183,400
Owned by Insiders
Owned by Institutions

Financial Efficiency

Recce Pharmaceuticals Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Recce Pharmaceuticals Ltd. is ―. Recce Pharmaceuticals Ltd.’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio0.00
Price to Fair Value
Price to FCF0.00
Price to Operating Cash Flow-7.08
PEG Ratio

Income Statement

In the last 12 months, Recce Pharmaceuticals Ltd. had revenue of 7.51M and earned -21.43M in profits. Earnings per share was -0.09.
Revenue7.51M
Gross Profit-2.94M
Operating Income-22.88M
Pretax Income-21.43M
Net Income-21.43M
EBITDA-20.33M
Earnings Per Share (EPS)-0.09

Cash Flow

In the last 12 months, operating cash flow was -20.44M and capital expenditures -26.35K, giving a free cash flow of -20.47M billion.
Operating Cash Flow-20.44M
Free Cash Flow-20.47M
Free Cash Flow per Share-0.07

Dividends & Yields

Recce Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.66
52-Week Price Change-24.53%
50-Day Moving Average0.41
200-Day Moving Average0.38
Relative Strength Index (RSI)44.68
Average Volume (3m)132.10K

Important Dates

Recce Pharmaceuticals Ltd. upcoming earnings date is Mar 2, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateMar 2, 2026
Ex-Dividend Date

Financial Position

Recce Pharmaceuticals Ltd. as a current ratio of ―, with Debt / Equity ratio of -95.06%
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Recce Pharmaceuticals Ltd. has paid -6.74M in taxes.
Income Tax-6.74M
Effective Tax Rate

Enterprise Valuation

Recce Pharmaceuticals Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Recce Pharmaceuticals Ltd. has AU$10.45M in cash and marketable securities with AU$4.74M in debt, giving a net cash position of -AU$319.44K billion.
Cash & Marketable SecuritiesAU$10.45M
Total DebtAU$4.74M
Net Cash-AU$319.44K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share

Margins

Gross margin is -23.29%, with operating margin of ―, and net profit margin of ―.
Gross Margin-23.29%
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Recce Pharmaceuticals Ltd. is AU$0.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetAU$0.50
Price Target Upside25.00% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast0.66%

Scores

Smart Score2
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis